These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 20002739)
1. Routine use of Xeomin in patients previously treated with Botox: long term results. Dressler D Eur J Neurol; 2009 Dec; 16 Suppl 2():2-5. PubMed ID: 20002739 [TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and tolerability of Xeomin in the treatment of blepharospasm. Jankovic J Eur J Neurol; 2009 Dec; 16 Suppl 2():14-8. PubMed ID: 20002742 [TBL] [Abstract][Full Text] [Related]
3. Xeomin in the treatment of cervical dystonia. Benecke R Eur J Neurol; 2009 Dec; 16 Suppl 2():6-10. PubMed ID: 20002740 [TBL] [Abstract][Full Text] [Related]
4. Comparing Botox and Xeomin for axillar hyperhidrosis. Dressler D J Neural Transm (Vienna); 2010 Mar; 117(3):317-9. PubMed ID: 20143241 [TBL] [Abstract][Full Text] [Related]
5. Hemifacial spasm and reinnervation synkinesias: long-term treatment with either Botox or Dysport. Kollewe K; Mohammadi B; Dengler R; Dressler D J Neural Transm (Vienna); 2010 Jun; 117(6):759-63. PubMed ID: 20437061 [TBL] [Abstract][Full Text] [Related]
6. Five-year experience with incobotulinumtoxinA (Xeomin(®) ): the first botulinum toxin drug free of complexing proteins. Dressler D Eur J Neurol; 2012 Mar; 19(3):385-9. PubMed ID: 22035051 [TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years. Sorgun MH; Yilmaz R; Akin YA; Mercan FN; Akbostanci MC J Clin Neurosci; 2015 Aug; 22(8):1319-25. PubMed ID: 26100157 [TBL] [Abstract][Full Text] [Related]
8. [Treatment with botulinum toxin in neurologic pediatrics]. Justus N; Lee SH; Berweck S; Heinen F Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921 [No Abstract] [Full Text] [Related]
9. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm. Bihari K Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis. Verma A; Steele J Muscle Nerve; 2006 Aug; 34(2):235-7. PubMed ID: 16583370 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin therapy of cervical dystonia: comparing onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin (®)). Dressler D; Tacik P; Adib Saberi F J Neural Transm (Vienna); 2014 Jan; 121(1):29-31. PubMed ID: 23913131 [TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis. Rosell K; Hymnelius K; Swartling C Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164 [TBL] [Abstract][Full Text] [Related]
14. Effects of botulinum toxin-B (BTX-B) injections for hemifacial spasm. Tousi B; Perumal JS; Ahuja K; Ahmed A; Subramanian T Parkinsonism Relat Disord; 2004 Oct; 10(7):455-6. PubMed ID: 15465407 [No Abstract] [Full Text] [Related]
15. Botulinum toxin for treatment of dystonia. Dressler D Eur J Neurol; 2010 Jul; 17 Suppl 1():88-96. PubMed ID: 20590814 [TBL] [Abstract][Full Text] [Related]
16. Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm. Bentivoglio AR; Fasano A; Ialongo T; Soleti F; Lo Fermo S; Albanese A Eur J Neurol; 2009 Mar; 16(3):392-8. PubMed ID: 19364366 [TBL] [Abstract][Full Text] [Related]
17. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature. Vergilis-Kalner IJ J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270 [TBL] [Abstract][Full Text] [Related]
18. [Neurologic indications of botulin in adults]. Sotaniemi K Duodecim; 2011; 127(22):2409-14. PubMed ID: 22238918 [TBL] [Abstract][Full Text] [Related]
20. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox. Badarny S; Susel Z; Honigman S Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]